• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED

11.1% ! 0.5¢
Market Cap $10.07M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM 04/07/25 25 6.3K
04/07/25 Last post  valueadd Comments Created with Sketch.  25  Views Created with Sketch.  6.3K 
CHM 04/07/25 42 15K
04/07/25 Last post  dalts66 Comments Created with Sketch.  42  Views Created with Sketch.  15K 
CHM 02/07/25 0 305
02/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  305 
CHM 01/07/25 0 308
01/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  308 
CHM 27/06/25 2 1.0K
27/06/25 Last post  valueadd Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
CHM 27/06/25 25 6.4K
27/06/25 Last post  dalts66 Comments Created with Sketch.  25  Views Created with Sketch.  6.4K 
CHM 18/06/25 25 6.5K
18/06/25 Last post  dalts66 Comments Created with Sketch.  25  Views Created with Sketch.  6.5K 
CHM
CHMO
18/06/25 6 2.1K
18/06/25 Last post  dalts66 Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 

See All Discussions arrow Created with Sketch.

Timeline

Initial Director's Interest Notice
02 Jul 17:07
 
Change of Director's Interest Notice LR
01 Jul 16:57
 
Professor Miles Prince appointed as Non-Executive Director
01 Jul 08:35
 
Notification of cessation of securities - CHM
26 Jun 16:14
 
Notice of Extraordinary General Meeting/Proxy Form
24 Jun 08:32
 
Translational data shows persistence of CHM CDH17
17 Jun 08:29
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $10.07M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $36.69K 7.556M

Buyers (Bids)

No. Vol. Price($)
32 22352035 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14512739 14
View Market Depth
Last trade - 16.10pm 04/07/2025 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 11.1 %)
Open High Low Volume
0.5¢ 0.5¢ 0.4¢ 6642526
Last updated 15.53pm 04/07/2025 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.